Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Locus-Tau: Biomarkers of the Locus Coeruleus Nucleus in Alzheimer's Disease Risk
NCT07007208Phase 2Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Feb 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Diagnostic capabilities of Locus Coeruleus biomarkers for a positive PET-Tau exam at 24 months. Started Feb 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07007208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07007208.